Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies.
Meyer
S C
SC
Sulzer
I
I
Lämmle
B
B
Kremer Hovinga
J A
JA
D051722:ADAM Proteins / Q000378:metabolism / Q000502:physiology*; D000071120:ADAMTS13 Protein; D000208:Acute Disease; D001663:Bilirubin / Q000737:chemistry; D002624:Chemistry, Clinical / Q000379:methods; D006402:Hematologic Diseases / Q000150:complications / Q000175:diagnosis; D006801:Humans; D006932:Hyperbilirubinemia / Q000097:blood* / Q000150:complications / Q000473:pathology; D007700:Kinetics; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood / Q000175:diagnosis*; D015203:Reproducibility of Results; D013997:Time Factors; D014841:von Willebrand Factor / Q000096:biosynthesis*
D014841:von Willebrand Factor; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human; D001663:Bilirubin